What is the recommended treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Chlamydia

The recommended first-line treatment for uncomplicated chlamydial infection is either azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days, both with approximately 97-98% efficacy rates. 1

First-Line Treatment Options

  • Azithromycin 1 g orally in a single dose

    • Advantages: Single-dose therapy, directly observed treatment possible, better compliance 1
    • Particularly useful when compliance with multi-day regimens is questionable 1
    • Microbial cure rate approximately 97% 1, 2
  • Doxycycline 100 mg orally twice daily for 7 days

    • Advantages: Lower cost, extensive clinical experience 1
    • Microbial cure rate approximately 98% 1, 2
    • Standard dosage for uncomplicated chlamydial infection 3

Alternative Treatment Options

For patients who cannot take first-line medications:

  • Erythromycin base 500 mg orally four times a day for 7 days 1
  • Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 1
  • Ofloxacin 300 mg orally twice a day for 7 days 1
  • Levofloxacin 500 mg orally once daily for 7 days 1, 4

Treatment During Pregnancy

  • Azithromycin 1 g orally in a single dose 4, 1
  • Amoxicillin 500 mg orally three times a day for 7 days 4, 1

Note: Doxycycline and ofloxacin are contraindicated during pregnancy 4, 1

Treatment Considerations

  • Meta-analyses show azithromycin and doxycycline are equally efficacious for genital chlamydial infections 1, 2, 5
  • Side effects are generally mild to moderate and primarily gastrointestinal for both medications 6, 2
  • Approximately 17-20% of patients experience side effects with either medication 2
  • When selecting treatment, consider:
    • Patient compliance (azithromycin preferred when compliance is a concern) 1, 7
    • Cost (doxycycline generally less expensive) 1, 4

Implementation Best Practices

  • Medications should be dispensed on-site when possible 1
  • First dose should be directly observed to maximize compliance 1
  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1
  • Patients should abstain from sexual intercourse until all sex partners are treated 1

Partner Management

  • All sex partners from the previous 60 days should be evaluated, tested, and treated 1
  • If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1

Follow-Up Recommendations

  • Test-of-cure is not recommended for patients treated with the recommended regimens unless:
    • Therapeutic compliance is questionable
    • Symptoms persist
    • Reinfection is suspected 1
  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection 1, 7

Special Considerations for Rectal Chlamydia

  • Doxycycline may be more effective than azithromycin for rectal chlamydial infections, with efficacy rates of 99.6% versus 82.9% respectively 8
  • For rectal infections, doxycycline 100 mg orally twice daily for 7 days should be considered the preferred treatment 8

Treatment in Children

  • For children ≥8 years who weigh >45 kg: Azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days 4
  • For children ≥8 years who weigh <45 kg: Treatment based on weight 4

By following these evidence-based recommendations, healthcare providers can effectively treat chlamydial infections and reduce the risk of complications and transmission.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.